BIORBYT LTD. Non-Antibody Products — page 2 of 7
Non-Antibody Products
Page 2,062 of 7,959
| Name | Description | Size | Catalog # | |
|---|---|---|---|---|
| HLA-DMB | n/a | 10 ug | orb528006 | More Info |
| HLA DMB (HLA-DMB) Human Over-expression Lysate | HLA HEK293T cell transient overexpression lysate (as WB positive control) | 20 ug | orb1365196 | More Info |
| HLA DMB (HLA-DMB) Human Over-expression Lysate | Transient overexpression lysate of major histocompatibility complex, class… | 100 ug | orb1344856 | More Info |
| HLA-DMB siRNA (Human) | siRNA to inhibit HLA-DMB expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1866136 | More Info |
| HLA DM (HLA-DMA) Human Over-expression Lysate | HLA HEK293T cell transient overexpression lysate (as WB positive control) | 20 ug | orb1367203 | More Info |
| HLA DM (HLA-DMA) Human Over-expression Lysate | Transient overexpression lysate of major histocompatibility complex, class… | 100 ug | orb1346864 | More Info |
| HLA-DOA | Vector will be determined during the manufacturing process, either pENTR22… | 10 ug | orb598785 | More Info |
| HLA-DOA Human Over-expression Lysate | HLA HEK293T cell transient overexpression lysate (as WB positive control) | 20 ug | orb1365195 | More Info |
| HLA-DOA Human Over-expression Lysate | Transient overexpression lysate of major histocompatibility complex, class… | 100 ug | orb1344855 | More Info |
| HLA-DOA peptide | The peptide is used to anti HLA-DOA antibody reactivity. Purity > 85%. | 5 mg, 1 mg | orb319359 | More Info |
| HLA-DOA siRNA (Human) | siRNA to inhibit HLA-DOA expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1866134 | More Info |
| HLA-DOB | Vector will be determined during the manufacturing process, either pENTR22… | 10 ug | orb598746 | More Info |
| HLA DOB (HLA-DOB) Human Over-expression Lysate | HLA HEK293T cell transient overexpression lysate (as WB positive control) | 20 ug | orb1378732 | More Info |
| HLA DOB (HLA-DOB) Human Over-expression Lysate | Transient overexpression lysate of major histocompatibility complex, class… | 100 ug | orb1358398 | More Info |
| HLA-DOB peptide | The peptide is used to block anti-HLA-DOB antibody reactivity. Purity > 85… | 5 mg, 1 mg | orb217393 | More Info |
| HLA-DOB siRNA (Human) | siRNA to inhibit HLA-DOB expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1866133 | More Info |
| HLA-DPA1 | Vector will be determined during the manufacturing process, either pENTR22… | 10 ug | orb596523 | More Info |
| HLA-DPA1 siRNA (Human) | siRNA to inhibit HLA-DPA1 expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1866132 | More Info |
| HLA-DPB1 | Vector will be determined during the manufacturing process, either pENTR22… | 10 ug | orb598800 | More Info |
| HLA-DPB1 Human Over-expression Lysate | HLA HEK293T cell transient overexpression lysate (as WB positive control) | 20 ug | orb1378731 | More Info |
| HLA-DPB1 Human Over-expression Lysate | Transient overexpression lysate of major histocompatibility complex, class… | 100 ug | orb1358397 | More Info |
| HLA-DPB1 siRNA (Human) | siRNA to inhibit HLA-DPB1 expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1866131 | More Info |
| HLA DP (HLA-DPA1) Human Over-expression Lysate | HLA HEK293T cell transient overexpression lysate (as WB positive control) | 20 ug | orb1376474 | More Info |
| HLA DP (HLA-DPA1) Human Over-expression Lysate | Transient overexpression lysate of major histocompatibility complex, class… | 100 ug | orb1356139 | More Info |
| HLA-DQA1 | Vector will be determined during the manufacturing process, either pENTR22… | 10 ug | orb598804 | More Info |
| HLADQA1 (HLA-DQA1) Human Over-expression Lysate | HLA HEK293T cell transient overexpression lysate (as WB positive control) | 20 ug | orb1378730 | More Info |
| HLADQA1 (HLA-DQA1) Human Over-expression Lysate | Transient overexpression lysate of major histocompatibility complex, class… | 100 ug | orb1358396 | More Info |
| HLA-DQA2 Human Over-expression Lysate | HLA HEK293T cell transient overexpression lysate (as WB positive control) | 20 ug | orb1370208 | More Info |
| HLA-DQA2 Human Over-expression Lysate | Transient overexpression lysate of major histocompatibility complex, class… | 100 ug | orb1349871 | More Info |
| HLA DQA2 Immunizing peptide | n/a | 100 ug | orb59903 | More Info |
| HLA-DQA2 Peptide | n/a | 0.1 mg | orb1235791 | More Info |
| HLA-DQA1 siRNA (Human) | siRNA to inhibit HLA-DQA1 expression using RNA interference. Purity > 97% | 15 nmol, 30 nmol | orb1866130 | More Info |
| HLA-DQA2 siRNA (Human) | siRNA to inhibit HLA-DQA2 expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1866129 | More Info |
| HLA-DQB1 | n/a | 10 ug | orb528002 | More Info |
| HLA-DQB2 | Vector will be determined during the manufacturing process, either pENTR22… | 10 ug | orb598784 | More Info |
| HLA-DQB1 Human Over-expression Lysate | HLA HEK293T cell transient overexpression lysate (as WB positive control) | 20 ug | orb1365200 | More Info |
| HLA-DQB1 Human Over-expression Lysate | Transient overexpression lysate of major histocompatibility complex, class… | 100 ug | orb1344860 | More Info |
| HLA-DQB2 Human Over-expression Lysate | HLA HEK293T cell transient overexpression lysate (as WB positive control) | 20 ug | orb1376133 | More Info |
| HLA-DQB2 Human Over-expression Lysate | Transient overexpression lysate of major histocompatibility complex, class… | 100 ug | orb1355798 | More Info |
| HLA-DQB1 peptide | The peptide is used to anti-HLA-DQB1 antibody reactivity. Purity > 85%. | 5 mg, 1 mg | orb234504 | More Info |
| HLA-DQB2 peptide | The peptide is used to block anti-HLA-DQB2 antibody reactivity. Purity > 8… | 5 mg, 1 mg | orb218831 | More Info |
| HLA-DQB1 siRNA (Human) | siRNA to inhibit HLA-DQB1 expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1866128 | More Info |
| HLA-DQB2 siRNA (Human) | siRNA to inhibit HLA-DQB2 expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1866127 | More Info |
| HLA-DRA | Vector will be determined during the manufacturing process, either pENTR22… | 10 ug | orb598795 | More Info |
| HLA-DRA Human Over-expression Lysate | HLA HEK293T cell transient overexpression lysate (as WB positive control) | 20 ug | orb1370143 | More Info |
| HLA-DRA Human Over-expression Lysate | Transient overexpression lysate of major histocompatibility complex, class… | 100 ug | orb1349806 | More Info |
| HLA-DRA siRNA (Human) | siRNA to inhibit HLA-DRA expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1866126 | More Info |
| HLA-DRB1 | Vector will be determined during the manufacturing process, either pENTR22… | 10 ug | orb598752 | More Info |
| HLA-DRB1 | n/a | 10 ug | orb528013 | More Info |
| HLA-DRB3 | Vector will be determined during the manufacturing process, either pENTR22… | 10 ug | orb598737 | More Info |
BIORBYT LTD.
BIORBYT LTD.
7 Signet Court
Swann Road
Cambridge, CB5 8LA U.K.
P: +44 (0)1223 859 353
F: +44(0)1223 280 240
info@biorbyt.com
http://www.biorbyt.com
U.S. OFFICE
Biorbyt LLC
1100 Corporate Square Drive
Helix Center, Suite 221
St Louis, MO 63132
Email: info@biorbyt.com
Phone: +1 (415) 906-5211
Fax: +1 (415) 651-8558
Return to Profile